National Reference Laboratory 1

1. Very little influenza in the WHO European Region during the 2020/21 season, weeks40 2020 to 8 2021
2. USE OF 15 MIRU-VNTR GENOTYPING FOR DISCRIMINATING M. TUBERCULOSIS CLINICAL ISOLATES FROM KAZAKHSTAN
3. Treatment outcomes of isoniazid-resistant (Rifampicin susceptible) tuberculosis patients in Uzbekistan, 2017–2018
4. Sex differences in risk factors for unsuccessful tuberculosis treatment outcomes in Eastern Europe from 2020 to 2022: a multi-country retrospective cohort study
5. Universal access to xpert mtb/rif testing for diagnosis of tuberculosis in uzbekistan: How well are we doing?
1